Table 3.
The types of treatment for COVID-19 patients.
| Expired | Recovered | Total | P-value | |
|---|---|---|---|---|
| N (%) | N (%) | N (%) | ||
| Lopinavir/Ritonavir | 43 (43.9) | 78 (39.8) | 121 (41.2) | 0.003 |
| Atazanavir/Ritonavir | 12 (12.2) | 15 (7.7) | 27 (9.2) | |
| Remdesivir | 12 (12.2) | 8 (4.1) | 20 (6.8) | |
| Interferon B1a | 11 (11.2) | 47 (24) | 58 (19.7) | |
| Favipiravir | 2 (2) | 17 (8.7) | 19 (6.5) | |
| Remdesivi + Interferon B1a | 17 (17.30) | 25 (12.8) | 42 (14.3) | |
| Favipiravir + Interferon B1a | 1 (1) | 6 (3.1) | 7 (2.4) | |
| Levofloxacin | 9 (9.2) | 94 (48) | 103 (35) | ≤0.001 |
| Azithromycin | 0 (0) | 28 (14.3) | 28 (9.5) | |
| Carbapenem | 3 (3.1) | 9 (4.6) | 12 (4.1) | |
| Levofloxacin + Vancomycin | 39 (39.8) | 53 (27) | 92 (31.3) | |
| Carbapenem + Levofloxacin + Vancomycin | 47 (48) | 3 (1.5) | 50 (17) | 0.05 |
| No Antibiotic | 0 (0) | 9 (4.6) | 9 (3.1) | |
| Corticosteroid | 64 (65.3) | 112 (57.1) | 176 (59.9) |
Bold p values are statically significant.